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The latest advances in bioorthogonal chemistry [1] demonstrate how organometallic compounds and inorganic materials are capable of catalyzing the activation of profluorescent substrates and prodrugs with remarkable efficiencyi nb iological environments. [2] [3] [4] [5] [6] [7] [8] [9] [10] These selective catalysts carry out non-natural reactions dodging the interference of biological molecules,i ns ome cases with endogenous cellular components as co-reactants. [3, 9] In this context, we recently reported anew bioorthogonal reaction in which riboflavin photoactivates aP t IV prodrug in acatalytic process under irradiation with extremely low doses of blue light and in the presence of zwitterionic electron donors.L ight activation of the riboflavin-prodrug pair triggers cisplatin-related antiproliferative activity in PC3 cancer cells. [11] Unlike in classic organometallic catalysis, where metals act as catalysts,i nt his reaction, the metal complex is an unconventional substrate, [12] and the biocompatible riboflavin acts as catalyst.
Herein, we report fundamental discoveries in this new area of bioorthogonal chemistry by 1) investigating the catalytic behavior of various flavin catalysts,i ncluding four flavoproteins with diverse biological functions and flavin binding pockets,2)increasing the pool of inorganic reactions to different Pt IV and Ru II prodrug complexes,and 3) evaluating the efficiencyo fd ifferent (bio)organic electron donors ( Figure 1 ). Furthermore,o ur work shows for the first time that certain flavoproteins may be directly implicated in the activation of metallodrugs under biologically relevant conditions in the absence of light.
Initially,w ei nvestigated the capability of FAD( flavin adenine dinucleotide) to act as ac atalyst for the photoactivation of two classes of anticancer metal complexes, namely octahedral Pt IV and Ru II -arene piano-stool complexes.C omplexes 1-3 are prodrugs of cisplatin and carboplatin, [13] and complexes 4 and 5 are photoactivatable scaffolds capable of generating reactive RuÀOH 2 species that can bind to biomacromolecules (Figure 2a) . [14] [15] [16] [17] Importantly,t hese Pt IV and Ru II complexes have poor absorption properties in the visible region (Figure 2b )compared to other photoactivatable complexes,s uch as Ru polypyridyl species. Therefore,novel strategies to prompt their photochemistry at longer wavelengths are pivotal for their use in photochemotherapy.C omplexes 1-5 are stable towards hydrolysis in the dark, and have either no or poor photoreactivity under blue light excitation. [11, 17, 18] FADp hotocatalysis towards 1-5 was performed employing 10 mm of catalyst and 200 mm of metal substrate (5 % catalyst loading). In all irradiation experiments,w eu sed an LED light source (6 mW cm
À2
)with an emission maximum at 460 nm and 1 HNMR analysis to monitor and quantify the evolution of the photoreactions.T he experimental methods and ac omplete set of dark and light-irradiation experiments are described in the Supporting Information (Figures S1-S76) .
First, we evaluated the effect of electron donors on the catalytic process using complex 1,with the aim of optimizing the reaction conditions.T hree concentrations (0.2, 2, and 20 mm)o fM ES (as buffer,p H6)o rN ADH in phosphate buffer (PB,p H7,1 00 mm)w ere employed for this purpose. MES was selected as an electron donor to follow up our previous work on riboflavin [11] while NADH was chosen for its relevance as ab iological cofactor in numerous reactions catalyzed by flavoenzymes. [19] Moreover,m etal-based cata-lytic drugs have been recently shown to kill cancer cells by interfering with cellular NAD + /NADH homeostasis. [20] [21] [22] Upon 460 nm light excitation, FADp hotoconverted the Pt IV substrate,a nd the catalytic efficiency increased linearly with the MES concentration. FADw as fully inactive in the dark at any tested MES concentration. In the absence of light, 0.2 or 2mm NADH did not induce any reaction for 1,whereas light irradiation switched on the generation of photoproducts at 2mm NADH when FADw as present. At 2mm NADH, FADp hotocatalyzed the full conversion of 1 in only 2.5 min whereas areaction time of 5-10 min was required with 20 mm MES.A tt he lowest concentration (0.2 mm), NADH was instantaneously photooxidized to NAD + by molecular oxygen (O 2 ), precluding any catalytic reaction between FADand the complex. Conversely,r eduction of 1 at 20 mm NADH took place readily in the dark when FADw as present, or under light irradiation when the flavin was absent (Figures S1-S8).
Based on these results,w eu sed 20 mm MES and 2mm NADH to determine the photocatalytic activity of FAD towards 1-5 ( Figure 2) . [23] All complexes underwent photochemical activation in the presence of catalytic quantities of FAD( Figures S1-S38 ). In line with their redox chemistry in biological contexts, [24] FADp hotoactivation of 1-4 with NADH was approximately twice as fast as that with MES. Theo nly exception was 5,f or which the FADt urnover frequency (TOF) was 3.4 times lower with NADH than with MES (Table 1 ).
Kinetic analysis of these catalytic reactions showed that the rate clearly depended on the nature of the substrate. Complexes 1, 2,a nd 4 were the best substrates,g iving the highest TOFs and total turnover numbers (TTNs). Remarkably,F AD enabled the quantitative conversion of 1 and 2 into the corresponding photoproducts regardless of the electron donor used.
With FAD, ac onvenient excitation wavelength (460 nm) and an extremely low light dose were employed for the S32) . [14] [15] [16] [17] Herein, we show that less than 15 min are sufficient to achieve comparable effects in 4 and 5 when FADisused as photocatalyst.
In cells,f lavins are bound to proteins through covalent and non-covalent interactions, [19] which control their (photo)-redox properties. [24] Exploiting flavoproteins as selective catalysts is therefore an exciting prospect for the design of bioorthogonal activation strategies for metal-based prodrugs. Accordingly,w es elected four flavoproteins for their diverse flavin-binding pockets and explored their capacity to catalyze the photoreduction of 1 and 2.T his part of the study was limited to these derivatives for their relevance as anticancer compounds [13, 25] with respect to the Ru II complexes 4 and 5. Furthermore,F AD displayed superior activity towards these Pt IV substrates compared to 3.T he use of 2 was also aimed at gauging the impact of the charge of the substrates on catalysis, with this complex featuring an eutral alkyl chain at the axial position rather than an egatively charged succinate as in 1.
Thef lavoprotein catalysts tested were miniSOG (mini singlet oxygen generator), [26] NOX( NADH oxidase from Thermus thermophilus), [27] GOX (glucose oxidase from Aspergillus niger), [28] and GR (glutathione reductase from S. cerevisiae). [29] MiniSOG is aflavin mononucleotide (FMN) containing small protein investigated as ag enetically encodable photosensitizer for the selective generation of singlet O 2 . [30] [31] [32] Theb acterial NOX enzyme generates hydrogen peroxide (H 2 O 2 )f rom O 2 by oxidizing NADH while the eukaryotic GOX naturally oxidizes glucose to H 2 O 2 and d-glucono-d-lactone.NOX and GOX have both been widely exploited in biocatalysis. [27, 33] GR is aN ADPH-dependent oxidoreductase exerting ac entral role in glutathione metabolism for most aerobic organisms. [34] GR was selected because unlike other flavoproteins,i td oes not generate reactive oxygen metabolites.
Different chemical environments surround the flavinbinding pockets in these four flavoproteins,c ontrolling solvent and substrate accessibility to the active site.A s shown in Figure 3 , the flavins are more exposed in miniSOG [35] and NOX than in GOX and GR, in which FADi s deeply buried in the protein scaffold. Thes olvent-accessible surface areas of the flavins are 45.50 2 for miniSOG and 67.92 2 for NOX, but only 2.39 2 for GOX and 4.01 2 for GR. Moreover,they display different electrostatic surfaces in the proximity of the flavin-binding pocket (Figures S39-S43 ). At pH 6-7, the NOXand GR active sites are neutral, whereas miniSOG and GOXd isplay positive and negative electrostatic charges,respectively.
Unless otherwise stated, photocatalysis experiments (Figures S44-S76 ) were performed by employing 10 mm of the flavoprotein catalysts,200 mm of 1 or 2,and either 20 mm MES or 2mm NADH to directly compare the activities with that of free flavin under the same conditions.T he concentrations of flavins bound to proteins were calibrated by optical methods according to the FADand FMN (for miniSOG) absorbance at 460 nm. Catalysis results for flavoproteins are summarized in Table 1 .
As anticipated from inspecting their flavin active sites, GOX and GR showed the lowest catalytic activity towards the Pt IV substrates.G OX presented no catalytic activity towards 1 under all of the experimental conditions tested. There was also no activity when glucose (20 mm), an atural substrate for the enzyme,w as employed as as ource of electrons instead of MES or NADH. Conversion of 2 by GOX occurred in the presence of both electron donors but the reactions were slow and did not reach completion after 1hof light irradiation (conversion < 40 %). With MES,G Rw as poorly or not active towards 1 and 2.Onthe contrary,the use of NADPH led to significantly higher TOFv alues and complete substrate conversion within af ew minutes of light exposure.
With MES,m iniSOG and NOX converted 1 and 2 exclusively into their photoproducts upon blue light excitation. Whereas miniSOG showed no preference between the two substrates,N OX was about seven times more reactive towards 2 than towards 1.L ight irradiation also switched on the catalytic activity of miniSOG in PB/NADH. Thef lavoprotein achieved full conversion of 200 mm 1 and 2 in about 4min. In the case of 1,i ti sa pproximately five times less efficient than free FMN (TOF = 35.6 AE 4.3 min À1 ; Figure S50 ). To our surprise,N OX behaved differently,a ctivating 1 and 2 in the dark when co-incubated with 2mm NADH. Under these conditions,1 0mm NOXc ompletely converted 1 in less than 7.5 min while free FADdid not give any reaction with 1 over 3h(see above). TheT OF values of 1 and 2 for NOXw ere estimated to be 4.3 AE 1.6 min À1 and 8.3 AE 1.6 min À1 ,r espectively,u sing less than 2 mm of the flavoprotein to allow for NMR reaction monitoring.
Thed iscovery of NOX catalytic activity in the dark has broad relevance for understanding the mechanism of action of Pt IV anticancer agents.Itisacommon assumption that Pt IV complexes are converted into active species by biological molecular reductants,s uch as glutathione or ascorbic acid, under physiological conditions. [37] Nevertheless,N OX-catalyzed activation of 1 and 2 in the presence of 2mm NADH is rapid and suggests that flavoproteins can provide alternative and highly efficient activation pathways for metallodrugs. [38] Considering that the cellular concentration of NADH is in the 0.1-0.2 mm range, [39] we evaluated the capacity of NOXto convert 200 mm 1 in the presence of an equimolar quantity of NADH in PB ( Figure S64 ). NOXn aturally uses O 2 as an electron acceptor to generate H 2 O 2 in the presence of NADH. [27] At such low concentrations,the enzyme consumed NADH too rapidly,p recluding any catalytic conversion of 1. Fort his reason, the reaction was studied under N 2 atmosphere.A ccordingly,w ed etermined that NOXc ould activate approximately 33 %o f1 in the absence of O 2 ,r evealing that flavoenzymes may indeed turn on Pt drug activity under certain cellular conditions,that is,hypoxia. Although the Pt IV conversion did not reach completion, the concentration of activated 1 should be sufficient to induce cell death in cancer tissues.
At higher concentrations of electron donor in aerated solution, the enzyme reaction pathway is altered by 1,w hich effectively competes with O 2 and intercepts electrons from the reduced flavoenzyme.I nf act, the activity of NOX increased by af actor of 2.3 while the production of H 2 O 2 simultaneously decreased (Figure 4a )w hen 1mm 1 was incubated with equimolar NADH. Under these conditions, the enzyme worked faster because it had access to higher concentrations of electron acceptors (1 and O 2 ), and produced lower amounts of H 2 O 2 because the hydride of NADH ought to be shared between the O 2 and metal complex reduction reactions.C onversely,m iniSOG production of H 2 O 2 is independent of the presence of 1 (Table S1) as it likely proceeds through photosensitization. [40] Thecapability of miniSOG and NOXtoact as bioorthogonal catalysts towards Pt IV prodrugs was investigated by using 1 in cell culture medium, where components such as proteins, vitamins,a nd salts can interfere with the activation process. Reactions in the presence of NADH (2 mm)s howed that miniSOG converted 1 in the biological environment only under light irradiation while the same reaction occurred already in the dark with NOX (Figure 4b and Figure S75 ). Thef lavoproteins almost retained the selectivity and efficiency of free FADunder these conditions ( Figure S76 ).
Am olecular description of the catalytic mechanism through which free flavins and flavoproteins activate Pt IV and Ru II complexes requires further investigations and is out of the scope of this manuscript. Our previous study suggests the catalysis is linked to the generation of the reduced forms of FADand FMN (e.g., FADH 2 and FMNH 2 ), either through photoinduced electron transfer (MES) or hydride transfer (NADH/NADPH). High levels of electron donors and light help increasing the catalytic efficiency of the flavins by stabilizing their active species and consequently enhancing the reaction rates.M etal complexes may form transient adducts with the reduced flavins and undergo chemical and photochemical transformations. [11] Nevertheless,itisclear from the results of this study that protein scaffolds play ac rucial role in governing the metal substrate access to the flavin catalytic site.T herefore,t he negatively charged electrostatic surface of GOXa nd the shielded channel in which its FADi sb ound prevent any interaction with negatively charged 1.C onsistently,w e observed that the consumption of glucose by GOX was not affected by the presence of an equimolar amount of 1 (Table S2) . Albeit with poor efficiency,G OX activated 2, which is in agreement with the absence of charged chemical groups in the complex and its lower reduction potential compared to that of 1. [41] In the case of miniSOG and NOX, however,t he protein scaffold enables the artificial catalysis by facilitating the formation of reduced FMN/FAD and favoring its stabilization for the subsequent electron transfer interaction with the Pt IV substrates.A ctually,m iniSOG and NOX have more solventexposed flavin units and suitable electrostatic surfaces to allow metal substrates to access the active site.T he role played by the protein scaffold is dramatic for NOX, which is an enzyme optimized by Nature to transfer hydrides from NADH to electron acceptors.C onsistently,N OX activity towards 1 and 2 is observed almost instantaneously in the dark with NADH. On the contrary,m iniSOG,aprotein derived from phototropin 2, which naturally does not use NADH as ac ofactor, requires light activation. Similar to NOXand in contrast to GOX, GR has amostly neutral FAD binding pocket, which enables the catalytic activation of 1 and 2.Nonetheless,GRrequires light triggering for catalysis likely owing to the limited accessibility of its FADw ith respect to NOX.
In conclusion, we have shown that free flavins and flavoproteins can catalyze artificial reactions of Pt IV and Ru II complexes,o perating either in the dark or upon light excitation. Some of these unconventional reactions have promising catalytic efficiency and bioorthogonal selectivity. These findings open new opportunities for the design of chemically and light-activated metal-based prodrugs,w hose biological effects could be triggered endogenously by bioorthogonal flavoprotein catalysts.
